MedPath

Effectiveness of dialectical behavior therapy for fatigue, depression, anxiety, stress and quality of life of patients with Multiple Sclerosis

Not Applicable
Conditions
Multiple Sclerosis.
Multiple sclerosis
Registration Number
IRCT20210720051948N1
Lead Sponsor
Islamic Azad University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Having MS diagnostic criteria based on McDonald's criteria
being at the age group of between 25 and 40 years
Having no severe attack and recurrence of the disease
Scored above 14 in depression scale (DASS-21)
Scored above 25 in anxiety scale (DASS-21)
Scored above 19 in stress scale (DASS-21)
being able to communicate and collaborate
Having interest in the study as well as inclination to participate in it

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depression, Anxiety, Stress. Timepoint: Prior to the study(before starting treatment), 60 days(right after ending the treatment) and finally 30 days later (after ending the treatment in follow-up stage). Method of measurement: Depression, Anxiety and Stress Scale (DASS-21).;Quality of life. Timepoint: Prior to the study(before starting treatment), 60 days(right after ending the treatment) and finally 30 days later (after ending the treatment in follow-up stage). Method of measurement: Quality of life questionnaire (MSQOL-54).;Fatigue. Timepoint: Prior to the study(before starting treatment), 60 days(right after ending the treatment) and finally 30 days later (after ending the treatment in follow-up stage). Method of measurement: Fatigue Severity Scale (FSS).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath